Deflazacort
Active substance: deflazacort
TABLET · DEFLAZACORT 30 mg/1
United StatesActive
Marketing holder: Upsher-Smith Laboratories, LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- DEFLAZACORT · 30 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2eb0-71dd-bd99-2a27060b532c,01a1208c-365a-77b5-8261-668288c94153,01a1208c-365b-78ac-b154-06950d266c77,01a1208c-3fdc-71d0-8f64-866becdbe010,01a1208c-4f39-7694-a423-d0e60c7dad73;count=54 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0832-0816
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0832-0816 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0832-0816 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0832-0816 · Verified 2026-10-09 · open in source